MAP Pharma (MAPP) Misses Q4 Views by 2c
- NXP Semi (NXPI) and Freescale Semi (FSL) to Merge in $40 Billion Deal
- Hewlett-Packard (HPQ) to Acquire Aruba Networks (ARUN) for $24.67/Share
- Pre-Open Stock Movers 03/02: (MVNR) (NXPI) (FSL) Higher; (LL) (WBAI) (PCRX) Lower (more...)
- Costco Wholesale (COST), Citi (C), Visa (V) Enter co-Branded Card Agreements
- Berkshire Hathaway (BRK-A) Reports Q4 EPS of $2,529; Comments on 'Next 50 Years'
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q4 loss of $0.46, 2 cents worse than the analyst estimate of ($0.44).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Realty Capital Properties (ARCP) Completes Internal Investigation; Restates Certain Financials
- Stratasys (SSYS) Misses Q4 EPS by 1c
- Seventy Seven Energy (SSE) Narrows Q4 Loss
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!